Literature DB >> 36177866

Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021.

Hannes Winner1, Janine Kimpel2, Florian Krammer3, Dorothee von Laer2, Jörg Paetzold1.   

Abstract

BackgroundAfter an outbreak of the SARS-CoV-2 Beta variant in the district of Schwaz/Austria, vaccination with Comirnaty vaccine (BNT162b2 mRNA, BioNTech-Pfizer) had been offered to all adult inhabitants (≥ 16 years) in March 2021. This made Schwaz one of the most vaccinated regions in Europe at that time (70% of the adult population took up the offer). In contrast, all other Austrian districts remained with low vaccine coverage.AimWe studied whether this rapid mass vaccination campaign provided indirect protection to unvaccinated individuals such as children (< 16 years) living in the same district.MethodsTo study the effect of the campaign we used two complementary approaches. We compared infection rates among the population of children (< 16 years) in Schwaz with (i) the child population from similar districts (using the synthetic control method), and (ii) with the child population from municipalities along the border of Schwaz not included in the campaign (using an event study approach).ResultsBefore the campaign, we observed very similar infection spread across the cohort of children in Schwaz and the control regions. After the campaign, we found a significant reduction of new cases among children of -64.5% (95%-CI: -82.0 to -30.2%) relative to adjacent border municipalities (using the event study model). Employing the synthetic control method, we observed a significant reduction of -42.8% in the same cohort.ConclusionOur results constitute novel evidence of an indirect protection effect from a group of vaccinated individuals to an unvaccinated group.

Entities:  

Keywords:  COVID-19; indirect protective effect; mass vaccination; population immunity

Mesh:

Substances:

Year:  2022        PMID: 36177866      PMCID: PMC9524054          DOI: 10.2807/1560-7917.ES.2022.27.39.2101027

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  18 in total

1.  The Economic Consequences of Hospital Admissions.

Authors:  Carlos Dobkin; Amy Finkelstein; Raymond Kluender; Matthew J Notowidigdo
Journal:  Am Econ Rev       Date:  2018-02

2.  Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.

Authors:  Vajeera Dorabawila; Dina Hoefer; Ursula E Bauer; Mary T Bassett; Emily Lutterloh; Eli S Rosenberg
Journal:  JAMA       Date:  2022-06-14       Impact factor: 157.335

3.  Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals.

Authors:  Oren Milman; Idan Yelin; Noga Aharony; Rachel Katz; Esma Herzel; Amir Ben-Tov; Jacob Kuint; Sivan Gazit; Gabriel Chodick; Tal Patalon; Roy Kishony
Journal:  Nat Med       Date:  2021-06-10       Impact factor: 53.440

4.  COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.

Authors:  Malia Skjefte; Michelle Ngirbabul; Oluwasefunmi Akeju; Daniel Escudero; Sonia Hernandez-Diaz; Diego F Wyszynski; Julia W Wu
Journal:  Eur J Epidemiol       Date:  2021-03-01       Impact factor: 8.082

5.  The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases.

Authors:  Guillaume Béraud; Sabine Kazmercziak; Philippe Beutels; Daniel Levy-Bruhl; Xavier Lenne; Nathalie Mielcarek; Yazdan Yazdanpanah; Pierre-Yves Boëlle; Niel Hens; Benoit Dervaux
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

6.  Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey.

Authors:  Ran D Goldman; Tyler D Yan; Michelle Seiler; Cristina Parra Cotanda; Julie C Brown; Eileen J Klein; Julia Hoeffe; Renana Gelernter; Jeanine E Hall; Adrienne L Davis; Mark A Griffiths; Ahmed Mater; Sergio Manzano; Gianluca Gualco; Naoki Shimizu; Thomas L Hurt; Sara Ahmed; Matt Hansen; David Sheridan; Samina Ali; Graham C Thompson; Nathalie Gaucher; Georg Staubli
Journal:  Vaccine       Date:  2020-10-10       Impact factor: 3.641

7.  COVID-19 herd immunity: where are we?

Authors:  Arnaud Fontanet; Simon Cauchemez
Journal:  Nat Rev Immunol       Date:  2020-10       Impact factor: 53.106

8.  Herd Immunity to COVID-19.

Authors:  Kamran Kadkhoda
Journal:  Am J Clin Pathol       Date:  2021-01-05       Impact factor: 2.493

9.  Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.

Authors:  Nick Andrews; Julia Stowe; Freja Kirsebom; Samuel Toffa; Tim Rickeard; Eileen Gallagher; Charlotte Gower; Meaghan Kall; Natalie Groves; Anne-Marie O'Connell; David Simons; Paula B Blomquist; Asad Zaidi; Sophie Nash; Nurin Iwani Binti Abdul Aziz; Simon Thelwall; Gavin Dabrera; Richard Myers; Gayatri Amirthalingam; Saheer Gharbia; Jeffrey C Barrett; Richard Elson; Shamez N Ladhani; Neil Ferguson; Maria Zambon; Colin N J Campbell; Kevin Brown; Susan Hopkins; Meera Chand; Mary Ramsay; Jamie Lopez Bernal
Journal:  N Engl J Med       Date:  2022-03-02       Impact factor: 91.245

10.  Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  JAMA Netw Open       Date:  2022-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.